COBALT CAPITAL ANNOUNCES INVESTMENT IN DITEBA RESEARCH LABORATORIES INC.Oakville, Ontario, November 19, 2007 – Cobalt Capital Partners, L.P. today announced the completion of an investment in Diteba Research Laboratories Inc. (“Diteba”), a Mississauga-based pharmaceutical / biopharmaceutical contract research organization specializing in providing GMP-compliant analytical and bioanalytical testing services to support drug development. “We believe that Diteba’s state-of-the-art, GMP-certified laboratory infrastructure, its highly qualified scientific staff and its emerging reputation as a specialist in analytical and bioanalytical chemistry related to novel compounds make it an excellent investment opportunity for us in a rapidly growing segment of the North American drug industry,” said Patrick Keane, President & Chief Executive Officer of Cobalt Capital Inc. “We are looking forward to working with Diteba’s exceptional management team to continue to grow their successful business.” “We are very proud that, in a relatively short period of time, Diteba has grown to a size where it represents an attractive investment for a group of seasoned business professionals like Cobalt Capital,” said Dr. Theo Kapanadze, Chief Scientific Officer of Diteba. “Our partnership with Cobalt Capital will yield significant benefits for Diteba, in that it will add knowledge of operational best practices to our own operational expertise, which will assist us in managing the dynamic growth of our business in a way that preserves the key advantages that we have become known for – our high level of industry expertise, academic innovation, strict GMP compliance, the ability to deliver the highest quality results on time and our focus on customer service.”
About Diteba Research Laboratories Inc. Diteba Research Laboratories Inc. is a contract research organization providing high value analytical and bioanalytical services to the pharmaceutical and biopharmaceutical industries. Diteba’s laboratory facility is located in Mississauga, Ontario and is licensed by Health Canada as a GMP (Good Manufacturing Practices) drug establishment, registered with the FDA and licensed by Health Canada to handle controlled drugs and substances.
About Cobalt Capital Cobalt Capital is a boutique private equity firm made up of former business owners and operators seeking to help private companies grow and innovate by investing their own capital and contributing their operating expertise. The partners of Cobalt Capital have significant business and entrepreneurial experience in a wide range of disciplines, sectors and geographies, and Cobalt Capital works closely with the companies in which it invests in order to help them achieve their growth objectives.
For more information please contact: Brian Atakhodjaev, CFA Scott Dunlop |
 |
